Moreover, consistent with this notion, our analysis of publicly available databases revealed that ERBIN expression inversely correlates with poor prognosis in breast and lung cancer, as well as with the expression of the mesenchymal markers CDH2 and SNAI1, and positively correlates with the expression of the epithelial marker CDH1. Here, CDH2 is linked to lung cancer.